Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

198 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pain and its treatment in hospitalized patients with metastatic cancer.
Cascinu S, Giordani P, Agostinelli R, Gasparini G, Barni S, Beretta GD, Pulita F, Iacorossi L, Gattuso D, Mare M, Munaò S, Labianca R, Todeschini R, Camisa R, Cellerino R, Catalano G. Cascinu S, et al. Among authors: beretta gd. Support Care Cancer. 2003 Sep;11(9):587-92. doi: 10.1007/s00520-003-0491-3. Epub 2003 Aug 5. Support Care Cancer. 2003. PMID: 12905055
Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: a low cost effective regimen.
Cascinu S, Baldelli AM, Catalano V, Giordani P, Beretta GD, Silva RR, Gasparini G, Mari D, Maisano R, Salvagni S, Barni S, Labianca R, Frontini L, Curti C, Catalano G. Cascinu S, et al. Among authors: beretta gd. Br J Cancer. 2002 Jan 21;86(2):213-7. doi: 10.1038/sj.bjc.6600046. Br J Cancer. 2002. PMID: 11870508 Free PMC article. Clinical Trial.
High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
Cascinu S, Scartozzi M, Labianca R, Catalano V, Silva RR, Barni S, Zaniboni A, D'Angelo A, Salvagni S, Martignoni G, Beretta GD, Graziano F, Berardi R, Franciosi V; Italian Group for the Study of Digestive Tract Cancer (GISCAD). Cascinu S, et al. Among authors: beretta gd. Br J Cancer. 2004 Apr 19;90(8):1521-5. doi: 10.1038/sj.bjc.6601752. Br J Cancer. 2004. PMID: 15083179 Free PMC article. Clinical Trial.
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial.
Rosati G, Lonardi S, Galli F, Di Bartolomeo M, Ronzoni M, Zampino MG, Banzi M, Zaniboni A, Pasini F, Bozzarelli S, Garattini SK, Ferrari D, Montesarchio V, Mambrini A, Ciuffreda L, Galli F, Pusceddu V, Carlomagno C, Bidoli P, Amoroso D, Bochicchio AM, Frassineti L, Corsi D, Bilancia D, Pastorino A, De Stefano A, Labianca R; TOSCA (Three or Six Colon Adjuvant) investigators. Rosati G, et al. Eur J Cancer. 2021 May;148:190-201. doi: 10.1016/j.ejca.2021.01.051. Epub 2021 Mar 18. Eur J Cancer. 2021. PMID: 33744715
Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracil.
Guglielmi A, Barni S, Zaniboni A, Pella N, Belvedere O, Beretta GD, Grossi F, Frontini L, Puglisi F, Labianca R, Sobrero A; Gruppo Italiano Studio Carcinomi Apparato Digerente. Guglielmi A, et al. Among authors: beretta gd. Br J Cancer. 2004 Oct 18;91(8):1428-33. doi: 10.1038/sj.bjc.6602176. Br J Cancer. 2004. PMID: 15381935 Free PMC article. Clinical Trial.
A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation.
Cascinu S, Berardi R, Salvagni S, Beretta GD, Catalano V, Pucci F, Sobrero A, Tagliaferri P, Labianca R, Scartozzi M, Crocicchio F, Mari E, Ardizzoni A. Cascinu S, et al. Among authors: beretta gd. Br J Cancer. 2008 Jan 15;98(1):71-6. doi: 10.1038/sj.bjc.6604121. Epub 2007 Dec 4. Br J Cancer. 2008. PMID: 18059397 Free PMC article. Clinical Trial.
Role of colony stimulating factors (CSFs) in solid tumours: results of an expert panel.
Gridelli C, Aapro MS, Barni S, Beretta GD, Colucci G, Daniele B, Del Mastro L, Di Maio M, De Petris L, Perrone F, Thatcher N, De Marinis F. Gridelli C, et al. Among authors: beretta gd. Crit Rev Oncol Hematol. 2007 Jul;63(1):53-64. doi: 10.1016/j.critrevonc.2007.01.008. Epub 2007 Mar 26. Crit Rev Oncol Hematol. 2007. PMID: 17368037 Review.
198 results